ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,066.00
-0.07%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36175
0.02%
Bitcoin
66,756.91
2.33%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aquestive Therapeutics Inc (AQST)

  7. Aquestive Therapeutics Inc (AQST) News

AQST

Aquestive Therapeutics (AQST)

Aquestive Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AQST
DateTimeSourceHeadlineSymbolCompany
05/13/202412:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
05/13/202412:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
05/09/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences ConferenceNASDAQ:AQSTAquestive Therapeutics Inc
05/07/20243:23PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AQSTAquestive Therapeutics Inc
05/07/20243:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
05/07/20243:19PMGlobeNewswire Inc.Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AQSTAquestive Therapeutics Inc
04/29/20246:00AMGlobeNewswire Inc.Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual FilmNASDAQ:AQSTAquestive Therapeutics Inc
04/25/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ETNASDAQ:AQSTAquestive Therapeutics Inc
04/12/20243:01PMGlobeNewswire Inc.Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of NeurologyNASDAQ:AQSTAquestive Therapeutics Inc
04/01/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNASDAQ:AQSTAquestive Therapeutics Inc
03/25/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common StockNASDAQ:AQSTAquestive Therapeutics Inc
03/19/20248:49PMGlobeNewswire Inc.Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common StockNASDAQ:AQSTAquestive Therapeutics Inc
03/19/20243:01PMGlobeNewswire Inc.Aquestive Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:AQSTAquestive Therapeutics Inc
03/14/20244:23PMGlobeNewswire Inc.Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA MeetingNASDAQ:AQSTAquestive Therapeutics Inc
03/11/20249:36AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
03/11/20249:36AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
03/11/20249:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
03/11/20249:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
03/11/20249:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
03/11/20249:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
03/11/20249:34AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
03/08/20243:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
03/05/20244:12PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AQSTAquestive Therapeutics Inc
03/05/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
03/05/20244:05PMGlobeNewswire Inc.Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:AQSTAquestive Therapeutics Inc
02/21/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ETNASDAQ:AQSTAquestive Therapeutics Inc
02/15/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual MeetingNASDAQ:AQSTAquestive Therapeutics Inc
02/14/20242:24PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AQSTAquestive Therapeutics Inc
02/12/20244:02PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AQSTAquestive Therapeutics Inc
01/30/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare ConferenceNASDAQ:AQSTAquestive Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AQST

Your Recent History

TSXV
BRAG.WT
Bragg Gaming
USOTC
DBSDF
DBS (PK)
NASDAQ
FGMC
FG Merger
BIT
UB8LJG
Unicredit Bank
CRTO
SUPERUSDT
SuperFarm
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved